• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Butterfly Network Inc.

    4/27/26 4:24:34 PM ET
    $BFLY
    Medical Electronics
    Health Care
    Get the next $BFLY alert in real time by email
    DEFA14A 1 ny20068165x2_defa14a.htm DEFA14A
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    SCHEDULE 14A INFORMATION
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934
     
    (Amendment No.  )
    Filed by the Registrant ☒
    ​ ​
    Filed by a party other than the Registrant   ☐
    Check the appropriate box:
    ☐
    ​ ​
    Preliminary Proxy Statement
     ☐
    ​ ​
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     ☐
    ​ ​
    Definitive Proxy Statement
     ☒
    ​ ​
    Definitive Additional Materials
     ☐
    ​ ​
    Soliciting Material under §240.14a-12
    BUTTERFLY NETWORK, INC.
    (Name of Registrant as Specified in Its Charter)
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
    Payment of Filing Fee (Check all boxes that apply):
    ☒
    ​ ​
    No fee required
     ☐
    ​ ​
    Fee paid previously with preliminary materials
     ☐
    ​ ​
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     Your Vote Counts!  BUTTERFLY NETWORK, INC. 1600 DISTRICT AVENUE  BURLINGTON, MA 01803  BUTTERFLY NETWORK, INC.  2025 Annual Meeting of Stockholders  Vote by June 11, 2025  11:59 PM ET  You invested in BUTTERFLY NETWORK, INC. and it’s time to vote!  You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the  availability of proxy materials for the stockholder meeting to be held on June 12, 2025.  Get informed before you vote  View the Notice and Proxy Statement, form of proxy and 2024 Annual Report online at www.ProxyVote.com OR you can receive a  free paper or email copy of the material(s) by requesting prior to May 29, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.  Vote Virtually at the Meeting*  June 12, 2025  11:00 a.m. Eastern Time  Virtually at: www.virtualshareholdermeeting.com/BFLY2025  *Please check the meeting materials for any special requirements for meeting attendance.  Smartphone users  Point your camera here and vote without entering a control number  For complete information and to vote, visit www.ProxyVote.com  Control #  V74538-P32333 
     

     Vote at www.ProxyVote.com  THIS IS NOT A VOTABLE BALLOT  This is an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. Please follow the instructions on the reverse side to vote these important matters.  Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.  Voting Items  Board Recommends  1. To elect seven directors to serve one-year terms expiring in 2026.  For  Nominees:  1a. Joseph DeVivo  1b. Jonathan M. Rothberg, Ph.D.  For  1c. Larry Robbins  For  1d. Dawn Carfora  For  1e. Elazer Edelman, M.D., Ph.D.  For  1f. S. Louise Phanstiel  For  1g. Erica Schwartz, M.D., J.D., M.P.H.  For  2. To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.  For  3. To approve by a non-binding advisory vote the compensation of the Company’s named executive officers, as disclosed in the proxy statement.  For  NOTE: In their discretion, the proxies are authorized to vote on such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.  V74539-P32333 
     
    Get the next $BFLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BFLY

    DatePrice TargetRatingAnalyst
    8/1/2025Outperform → Perform
    Oppenheimer
    7/1/2025$3.00Buy
    Craig Hallum
    3/17/2025Outperform
    William Blair
    9/10/2024$3.00Buy
    Lake Street
    3/29/2023$2.25Neutral
    UBS
    11/29/2022$4.50Outperform
    Oppenheimer
    10/4/2022$9.50Buy
    B. Riley Securities
    12/17/2021$7.00Neutral
    UBS
    More analyst ratings

    $BFLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference

    The Company presentation will occur at 8:40 AM CT on Thursday, June 4, 2026 Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), today announced that the company will participate at the William Blair 46th Annual Growth Stock Conference. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer will participate in a presentation breakout session at 8:40 AM CT on June 4, 2026, and host one-on-one investor meetings throughout the day. A webcast of the presentation will be available in the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations). To schedule a one-on-one meet

    5/21/26 4:05:00 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts

    Issued on behalf of Ventripoint Diagnostics Ltd.A Toronto-based small-cap is converting clinical validation into real-world hospital deployments at the moment AI cardiac imaging procurement is reorganizing globallyNEW YORK, May 19, 2026 /CNW/ -- USA News Group News Commentary — Cardiology has become one of the proving grounds for medical artificial intelligence, and the procurement environment around it has shifted hard in the last twelve months. Hospital networks are no longer content to evaluate clinical accuracy in isolation; they want department-level economic proof before they sign deployment contracts. That shift is reshaping which AI imaging companies can convert pilot data into recur

    5/19/26 8:55:00 AM ET
    $BFLY
    $GEHC
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Computer Software: Programming Data Processing

    A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

    VMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The AI-cardiac-diagnostics category is one of the more measurable inflection points in the broader medtech sector heading into the second half of 2026. The global AI cardiology market is projected to reach approximately US$2.78 billion in 2026 and climb past US$14 billion by 2034 as software-based diagnostics replace hardware-based imaging across an aging patient base and a healthcare system increasingly cost-pressured at

    5/13/26 9:00:00 AM ET
    $BFLY
    $CTKB
    $HTFL
    Medical Electronics
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BFLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    William Blair initiated coverage on Butterfly Network

    William Blair initiated coverage of Butterfly Network with a rating of Outperform

    3/17/25 7:23:53 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Phanstiel S. Louise bought $571,160 worth of shares (185,261 units at $3.08) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/17/25 4:10:13 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $64,471 worth of shares (21,370 units at $3.02) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/15/25 6:20:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $4,652,773 worth of shares (1,558,541 units at $2.99) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/5/25 5:40:49 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Neubauer Caroll H was granted 73,170 shares (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    5/21/26 4:10:27 PM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Neubauer Caroll H

    3 - Butterfly Network, Inc. (0001804176) (Issuer)

    5/21/26 4:09:38 PM ET
    $BFLY
    Medical Electronics
    Health Care

    CAO and SVP, Finance Carlson Megan sold $524,394 worth of shares (110,422 units at $4.75), decreasing direct ownership by 18% to 507,209 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    5/5/26 4:05:29 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    SEC Filings

    View All

    Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Butterfly Network, Inc. (0001804176) (Filer)

    5/8/26 8:07:20 AM ET
    $BFLY
    Medical Electronics
    Health Care

    SEC Form 10-Q filed by Butterfly Network Inc.

    10-Q - Butterfly Network, Inc. (0001804176) (Filer)

    4/30/26 7:33:32 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Butterfly Network, Inc. (0001804176) (Filer)

    4/30/26 7:01:43 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Financials

    Live finance-specific insights

    View All

    Butterfly Network Reports First Quarter 2026 Financial Results

    Delivered Revenue Above Consensus and Beat Adjusted EBITDA Guidance Reaffirmed full year Revenue and Adjusted EBITDA Guidance Delivered quarterly Revenue of $26.5 million in Q1, representing 25% YoY growth Delivered 69% Gross Margin up 600 bps and Adjusted EBITDA of ($6.1M) up 32% YoY Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the first quarter ended March 31, 2026, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "Butterfly opened the year with ano

    4/30/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report first quarter 2026 financial results on Thursday, April 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on April 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website at Events & Presentations.

    4/16/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Reports Fourth Quarter 2025 Financial Results

    Delivered Record Annual and Quarterly Revenue Reported quarterly record Revenue of $31.5 million in Q4, representing 41% YoY growth Generated positive net cash flow of $6.3 million in Q4 and lowest annual cash usage in company history Midjourney partnership contributed $6.8 million of revenue in Q4, advancing Butterfly Embedded™ platform strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's Presiden

    2/26/26 6:30:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Leadership Updates

    Live Leadership Updates

    View All

    A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

    VMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The AI-cardiac-diagnostics category is one of the more measurable inflection points in the broader medtech sector heading into the second half of 2026. The global AI cardiology market is projected to reach approximately US$2.78 billion in 2026 and climb past US$14 billion by 2034 as software-based diagnostics replace hardware-based imaging across an aging patient base and a healthcare system increasingly cost-pressured at

    5/13/26 9:00:00 AM ET
    $BFLY
    $CTKB
    $HTFL
    Medical Electronics
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Butterfly Network Appoints Caroll H. Neubauer to Board of Directors

    Seasoned Medtech Leader and Former Chairman and CEO of B. Braun of America Brings Deep Healthcare Industry Expertise Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective May 18, 2026. Mr. Neubauer will serve on the Board's Compensation Committee and Technology Committee. Mr. Neubauer has achieved a distinguished career spanning three decades with B. Braun, including serving for 29 years on the Global Management Board of the B. Braun Group of Companies. During his tenure, he helped grow annual revenue

    5/8/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS

    Prominent POCUS thought leader joins to advance clinical strategy and further Butterfly's mission to democratize ultrasound worldwide. Butterfly Network (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company's core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts. Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, educ

    4/21/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $BFLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    9/3/24 7:10:06 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13D/A filed by Butterfly Network Inc.

    SC 13D/A - Butterfly Network, Inc. (0001804176) (Subject)

    8/30/24 4:05:41 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by Butterfly Network Inc.

    SC 13G/A - Butterfly Network, Inc. (0001804176) (Subject)

    7/8/24 4:32:42 PM ET
    $BFLY
    Medical Electronics
    Health Care